Integrated BioPharma, Inc. OTC:INBP

Founder-led company

Integrated BioPharma stock price today

$0.263
-0.06
-20.38%
Financial Health
0
1
2
3
4
5
6
7
8
9

Integrated BioPharma stock price monthly change

+57.14%
month

Integrated BioPharma stock price quarterly change

+57.14%
quarter

Integrated BioPharma stock price yearly change

+43.48%
year

Integrated BioPharma key metrics

Market Cap
10.18M
Enterprise value
13.71M
P/E
19.5
EV/Sales
0.25
EV/EBITDA
5.19
Price/Sales
0.21
Price/Book
0.62
PEG ratio
-0.37
EPS
0.06
Revenue
52.50M
EBITDA
1.71M
Income
1.83M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
4.12%
Oper. margin
2.67%
Gross margin
10.18%
EBIT margin
2.67%
EBITDA margin
3.27%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Integrated BioPharma stock price history

Integrated BioPharma stock forecast

Integrated BioPharma financial statements

Integrated BioPharma, Inc. (OTC:INBP): Profit margin
Jun 2022 13.26M 1.49M 11.26%
Mar 2023 13.09M 16K 0.12%
Jun 2023 12.99M 40K 0.31%
Mar 2024 13.14M 285K 2.17%
Integrated BioPharma, Inc. (OTC:INBP): Debt to assets
Dec 2022 26052000 7.4M 28.4%
Mar 2023 26880000 8.13M 30.28%
Jun 2023 25431000 6.57M 25.83%
Mar 2024 26942000 8.03M 29.81%
Integrated BioPharma, Inc. (OTC:INBP): Cash Flow
Jun 2022 2.70M -35K -2.60M
Mar 2023 1.47M -16K -10K
Jun 2023 -1.18M -17K -10K
Mar 2024 1.64M -345K -10K

Integrated BioPharma alternative data

Integrated BioPharma, Inc. (OTC:INBP): Employee count
Aug 2023 147
Sep 2023 147
Oct 2023 141
Nov 2023 141
Dec 2023 141
Jan 2024 141
Feb 2024 141
Mar 2024 141
Apr 2024 141
May 2024 141
Jun 2024 141
Jul 2024 141

Integrated BioPharma other data

0.07% 0.00%
of INBP is owned by hedge funds
20K +0
shares is hold by hedge funds

Integrated BioPharma, Inc. (OTC:INBP): Insider trades (number of shares)
Period Buy Sel
Jun 2012 3 250000
Transaction Date Insider Security Shares Price per share Total value Source
Option
KAY E GERALD director, 10 perc.. Stock Option (right to buy) 100,000 $0.23 $23,000
Option
KAY E GERALD director, 10 perc.. Common Stock 100,000 $0.23 $23,000
Sale
KAY E GERALD director, 10 perc.. COMMON STOCK 250,000 $0.09 $22,500
Purchase
CD FINANCIAL, LLC 10 percent owner
6% secured convertible note due 2017 1 N/A N/A
Purchase
DESANTIS CARL director, 10 percent owner
6% secured convertible note due 2017 1 $0.65 $1
Purchase
MILMOE WILLIAM H. director, 10 percent owner
6% secured convertible note due 2017 1 $0.65 $1
Purchase
DESANTIS CARL director, 10 percent owner
Common Stock 87,111 $0.53 $46,169
Purchase
KAY E GERALD director, 10 perc.. Common Stock 100,000 $0.36 $36,000
Purchase
CD FINANCIAL, LLC 10 percent owner
Series C Convertible Preferred Stock; stated value $1000 108 $2 $216
Option
CANARICK ROBERT director
Common Stock 10,000 $3.5 $35,000
Insider Compensation
Ms. Dina L. Masi (1961) Senior Vice President, Chief Financial Officer & Sec.
$251,880
Mr. E. Gerald Kay (1936) Founder, Executive Chairman & Pres $240,650
Ms. Christina Kay (1970) Co-Chief Executive Officer & Director $226,990
Ms. Riva Kay Sheppard (1967) Co-Chief Executive Officer & Director
$225,920
  • What's the price of Integrated BioPharma stock today?

    One share of Integrated BioPharma stock can currently be purchased for approximately $0.26.

  • When is Integrated BioPharma's next earnings date?

    Unfortunately, Integrated BioPharma's (INBP) next earnings date is currently unknown.

  • Does Integrated BioPharma pay dividends?

    No, Integrated BioPharma does not pay dividends.

  • How much money does Integrated BioPharma make?

    Integrated BioPharma has a market capitalization of 10.18M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 0.7% to 50.32M US dollars.

  • What is Integrated BioPharma's stock symbol?

    Integrated BioPharma, Inc. is traded on the OTC under the ticker symbol "INBP".

  • What is Integrated BioPharma's primary industry?

    Company operates in the Consumer Defensive sector and Packaged Foods industry.

  • How do i buy shares of Integrated BioPharma?

    Shares of Integrated BioPharma can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Integrated BioPharma's key executives?

    Integrated BioPharma's management team includes the following people:

    • Ms. Dina L. Masi Senior Vice President, Chief Financial Officer & Sec.(age: 64, pay: $251,880)
    • Mr. E. Gerald Kay Founder, Executive Chairman & Pres(age: 89, pay: $240,650)
    • Ms. Christina Kay Co-Chief Executive Officer & Director(age: 55, pay: $226,990)
    • Ms. Riva Kay Sheppard Co-Chief Executive Officer & Director(age: 58, pay: $225,920)
  • Is Integrated BioPharma founder-led company?

    Yes, Integrated BioPharma is a company led by its founder Mr. E. Gerald Kay.

  • How many employees does Integrated BioPharma have?

    As Jul 2024, Integrated BioPharma employs 141 workers.

  • When Integrated BioPharma went public?

    Integrated BioPharma, Inc. is publicly traded company for more then 28 years since IPO on 30 Oct 1996.

  • What is Integrated BioPharma's official website?

    The official website for Integrated BioPharma is ibiopharma.com.

  • Where are Integrated BioPharma's headquarters?

    Integrated BioPharma is headquartered at Building 15, Hillside, NJ.

  • How can i contact Integrated BioPharma?

    Integrated BioPharma's mailing address is Building 15, Hillside, NJ and company can be reached via phone at +888 3196962.

Integrated BioPharma company profile:

Integrated BioPharma, Inc.

ibiopharma.com
Exchange:

OTC

Full time employees:

147

Industry:

Packaged Foods

Sector:

Consumer Defensive

Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized healthcare providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brands, as well as other branded proprietary nutraceutical products. This segment also sells private label vitamin and nutritional supplement products through the Internet; provides warehousing and fulfilment services; and distributes fine natural botanicals, including multi minerals, as well as raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.

Building 15
Hillside, NJ 07205

CIK: 0001016504
ISIN: US45811V1052
CUSIP: 45811V105